Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece-Reference-Cited by-同舟云学术

Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece

Published:2019-02-19 Issue:9 Volume:58 Page:1040-1044
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Befon Angeliki¹,Tzanetakou Vassiliki¹,Panagiotopoulos Antonios¹,Chasapi Vasiliki¹,Antoniou Christina¹,Stratigos Alexander J.¹^ORCID

Affiliation:

1. 1st Department of Dermatology‐Venereology National and Kapodistrian University of Athens and State Department of Dermatology‐Venereology Andreas Sygros Hospital Athens Greece

Funder

Meda, a Mylan Company

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.14397

Reference20 articles.

1. Actinic keratosis and field cancerisation;Stockfleth E;Eur J Dermatol,2011

2. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version

3. Epidemiology of Actinic Keratoses

4. The importance of treating the field in actinic keratosis

5. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review;American Journal of Clinical Dermatology;2024-02-13

2. Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches;Journal of Skin Cancer;2021-06-19

3. Imiquimod;Reactions Weekly;2019-09